Literature DB >> 15895306

Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy.

P Kapeller1, S Ropele, C Enzinger, T Lahousen, S Strasser-Fuchs, R Schmidt, F Fazekas.   

Abstract

Multiple sclerosis (MS) plaques and age related white matter lesions (WML) are of similar morphological appearance on T2 weighted MRI. Therefore their differentiation is sometimes crucial. Proton magnetic resonance spectroscopy ((1)H-MRS) adds metabolic information to conventional imaging and may help to distinguish inflammatory MS plaques from vascular related WML. This study was performed to evaluate the metabolite pattern in MS plaques and WML. 15 MS patients, 14 elderly individuals with WML and 16 controls were investigated by conventional MRI and short echo quantitative (1)H-MRS (TE: 30ms, TR: 3000ms). The mean metabolite concentrations in normal control white matter (NCWM), MS plaques and WML were: t-NAA: 8.96 mmol/l (SD: 0.93) vs 6.79 mmol/l (SD: 1.99) vs 7.18 mmol/l (SD: 1.41); Cho:1.66 mmol/l (SD: 0.4) vs 1.49 mmol/l (SD: 0.45) vs 1.46 mmol/l (SD: 0.34); PCr:5.64 mmol/l (SD: 0.83) vs 4.9mmol/l (SD: 1.3) vs 4.95 mmol/l (SD: 0.86); myo-Ins: 4.57 mmol/l (SD:1.05) vs 6.34 mmol/l (SD: 2.03) vs 4.5 mmol/l (SD: 0.96). t-NAA reduction in MS plaques and WML was significant compared with controls (p <or= 0.001). MS plaques showed significantly elevated myo- Ins concentrations compared with controls (p = 0.002) and to WML (p = 0.003). In summary MS plaques and WML show a decrease in their t-NAA concentrations compared with controls. Elevated concentrations of myo-Ins in MS plaques but not in WML makes this metabolite of special interest for their differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895306     DOI: 10.1007/s00415-005-0847-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

1.  Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis.

Authors:  F Fazekas; H Offenbacher; S Fuchs; R Schmidt; K Niederkorn; S Horner; H Lechner
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

2.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis.

Authors:  M A van Walderveen; W Kamphorst; P Scheltens; J H van Waesberghe; R Ravid; J Valk; C H Polman; F Barkhof
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

3.  Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates.

Authors:  F Fazekas
Journal:  Eur Neurol       Date:  1989       Impact factor: 1.710

4.  The participation of N-acetyl-L-aspartic acid in brain metabolism.

Authors:  H C Buniatian; V S Hovhannissian; G V Aprikian
Journal:  J Neurochem       Date:  1965-08       Impact factor: 5.372

5.  Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study.

Authors:  R Schmidt; F Fazekas; M Hayn; H Schmidt; P Kapeller; G Roob; H Offenbacher; M Schumacher; B Eber; V Weinrauch; G M Kostner; H Esterbauer
Journal:  J Neurol Sci       Date:  1997-11-06       Impact factor: 3.181

6.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells.

Authors:  A Brand; C Richter-Landsberg; D Leibfritz
Journal:  Dev Neurosci       Date:  1993       Impact factor: 2.984

Review 7.  Neuropathology in multiple sclerosis: new concepts.

Authors:  H Lassmann
Journal:  Mult Scler       Date:  1998-06       Impact factor: 6.312

8.  Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging.

Authors:  P Scheltens; F Barkhof; D Leys; E C Wolters; R Ravid; W Kamphorst
Journal:  Neurology       Date:  1995-05       Impact factor: 9.910

9.  Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations.

Authors:  P A Brex; G J Parker; S M Leary; P D Molyneux; G J Barker; C A Davie; A J Thompson; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

10.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.

Authors:  D T Chard; C M Griffin; M A McLean; P Kapeller; R Kapoor; A J Thompson; D H Miller
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

View more
  11 in total

1.  Miniature pig magnetic resonance spectroscopy model of normal adolescent brain development.

Authors:  Meghann C Ryan; Peter Kochunov; Paul M Sherman; Laura M Rowland; S Andrea Wijtenburg; Ashley Acheson; L Elliot Hong; John Sladky; Stephen McGuire
Journal:  J Neurosci Methods       Date:  2018-08-09       Impact factor: 2.390

Review 2.  Multiple sclerosis: the role of MR imaging.

Authors:  Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

Review 3.  Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.

Authors:  Andre D Furtado; Rafael Ceschin; Stefan Blüml; Gary Mason; Regina I Jakacki; Hideho Okada; Ian F Pollack; Ashok Panigrahy
Journal:  Neuroimaging Clin N Am       Date:  2017-02       Impact factor: 2.264

4.  Insular cortex metabolite changes in obstructive sleep apnea.

Authors:  Santosh K Yadav; Rajesh Kumar; Paul M Macey; Mary A Woo; Frisca L Yan-Go; Ronald M Harper
Journal:  Sleep       Date:  2014-05-01       Impact factor: 5.849

5.  Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis.

Authors:  Ivan I Kirov; Assaf Tal
Journal:  Magn Reson Med       Date:  2019-08-08       Impact factor: 4.668

6.  In vivo mapping of brain myo-inositol.

Authors:  Mohammad Haris; Kejia Cai; Anup Singh; Hari Hariharan; Ravinder Reddy
Journal:  Neuroimage       Date:  2010-10-14       Impact factor: 6.556

7.  1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage.

Authors:  Liat Ben Sira; Elka Miller; Moran Artzi; Aviva Fattal-Valevski; Shlomi Constantini; Dafna Ben Bashat
Journal:  Pediatr Radiol       Date:  2009-10-22

8.  Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.

Authors:  M P Wattjes; M Harzheim; G G Lutterbey; L Klotz; H H Schild; F Träber
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

Review 9.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

10.  Magnetic resonance spectroscopy markers of axons and astrogliosis in relation to specific features of white matter injury in preterm infants.

Authors:  Jessica L Wisnowski; Vincent J Schmithorst; Tena Rosser; Lisa Paquette; Marvin D Nelson; Robin L Haynes; Michael J Painter; Stefan Blüml; Ashok Panigrahy
Journal:  Neuroradiology       Date:  2014-06-06       Impact factor: 2.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.